AnalyzeDirect

Niccolini F, Foltynie T, Reis Marques T, Searle G, Natesan S, Kapur S, Rabiner E, Gunn R, Piccini P, Politis M. Loss of phosphodiesterase 10A signalling is associated with progression and severity in patients with Parkinson’s disease. Abstract. J Nucl Med. May 2015;56(supplement 3):31.

Full Text – Open Access

Publication Date
May 2015

How Analyze was Used
“Striatum (caudate and putamen) and globus pallidus ROIs were manually delineated using ANALYZE 11.”

Keywords
Algorithms
Caudate Nucleus
Cerebellum
Corpus Striatum
Disease Progression
Dyskinesias
Globus Pallidus
Humans
IMA107
Levodopa
Magnetic Resonance Imaging (MRI)
Male
Neostriatum
Parkinson Disease
Phosphoric Diester Hydrolases
Positron-Emission Tomography (PET)
Putamen

Author Affiliation(s)
Department of Basic and Clinical Neuroscience, King’s College London, London, UK. (FN, MP)

Sobell Department of Motor Neuroscience, UCL, London, UK. (TF)

Department of Psychosis Studies, King’s College London, London, UK. (TRM, SN, SK)

Imanova, London, UK. (GS, ER, RG)

Imperial College London, London, UK. (PP)

ID# 2746

Tags: Algorithms, Caudate Nucleus, Cerebellum, Corpus Striatum, Disease Progression, Dyskinesias, Globus Pallidus, Humans, IMA107, Levodopa, Magnetic Resonance Imaging (MRI), Male, Neostriatum, Parkinson Disease, Phosphoric Diester Hydrolases, Positron Emission Tomography (PET), Putamen